- Home
- ABSI
ABSI
Absci Corporation
as 11-22-2024 4:00pm EST
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.
| Founded: | 2011 | Country: | United States |
| Employees: | N/A | City: | VANCOUVER |
| Market Cap: | 457.6M | IPO Year: | 2021 |
| Target Price: | $8.67 | AVG Volume (30 days): | 1.5M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.93 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.35 - $6.72 | Next Earning Date: | 11-12-2024 |
| Revenue: | $4,207,000 | Revenue Growth: | -39.35% |
| Revenue Growth (this year): | 9.36% | Revenue Growth (next year): | 198.59% |
Latest Absci Corporation News
ABSI Breaking Stock News: Dive into ABSI Ticker-Specific Updates for Smart Investing
GlobeNewswire
2 days ago
Absci to Participate in the 36th Annual Piper Sandler Healthcare Conference
GuruFocus.com
10 days ago
Absci Corp (ABSI) Q3 2024 Earnings Call Highlights: Strategic Partnerships and Financial Challenges
Thomson Reuters StreetEvents
10 days ago
Q3 2024 Absci Corp Earnings Call
Zacks
11 days ago
Absci Corporation (ABSI) Reports Q3 Loss, Misses Revenue Estimates
GlobeNewswire
11 days ago
Absci Reports Business Updates and Third Quarter 2024 Financial and Operating Results
GuruFocus.com
12 days ago
Absci Corp (ABSI) Q3 2024 Earnings Report Preview: What to Look For
GlobeNewswire
16 days ago
Absci to Host R&D Day on December 12, 2024
GlobeNewswire
23 days ago
Absci and Twist Bioscience Collaborate to Design Novel Antibody using Generative AI
Compare ABSI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ABSI Absci Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.